Literature DB >> 15982792

Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.

Sabrina Capo1, Sandra Nuti, Maria Scarselli, Simona Tavarini, Silvia Montigiani, Elena Mori, Oretta Finco, Sergio Abrignani, Guido Grandi, Giuliano Bensi.   

Abstract

In the present study, we performed in silico analysis of Chlamydia pneumoniae genome sequence to identify human HLA-A2-restricted T cell epitopes. Thirty-one Chlamydia-specific protein antigens were selected and peptides were derived thereof using an HLA-A2 epitope predictive algorithm. Firstly, we tested binding of 55 selected 9mer peptides to HLA-A2 in vitro. Next, infection of HLA-A2 transgenic mice with C. pneumoniae elementary bodies and assessment of effector CD8+ T cells allowed us to identify which of the epitopes binding to HLA-A2 in vitro were recognized by C. pneumoniae infection-primed CD8+ T cells. Finally, we could confirm that CD8+ T cells in association with HLA-A2 recognized the most reactive peptides when the corresponding full-length genes were used to DNA-immunize HLA-A2 transgenic mice. By using this approach, a novel HLA-A2-restricted epitope in the outer membrane protein A (OmpA) of C. pneumoniae was identified, which proved to mediate specific lysis of peptide-loaded target cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982792     DOI: 10.1016/j.vaccine.2005.04.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Role of CD8(+)T cells in the host response to Chlamydia.

Authors:  Benjamin Wizel; Johanna Nyström-Asklin; Claudio Cortes; Amy Tvinnereim
Journal:  Microbes Infect       Date:  2008-08-26       Impact factor: 2.700

2.  Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.

Authors:  Michele D Picard; Jean-Luc Bodmer; Todd M Gierahn; Alexander Lee; Jessica Price; Kenya Cohane; Veronica Clemens; Victoria L DeVault; Galina Gurok; Robert Kohberger; Darren E Higgins; George R Siber; Jessica Baker Flechtner; William M Geisler
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

3.  NERVE: new enhanced reverse vaccinology environment.

Authors:  Sandro Vivona; Filippo Bernante; Francesco Filippini
Journal:  BMC Biotechnol       Date:  2006-07-18       Impact factor: 2.563

Review 4.  Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery.

Authors:  Mattia Dalsass; Alessandro Brozzi; Duccio Medini; Rino Rappuoli
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561

Review 5.  From empiricism to rational design: a personal perspective of the evolution of vaccine development.

Authors:  Ennio De Gregorio; Rino Rappuoli
Journal:  Nat Rev Immunol       Date:  2014-06-13       Impact factor: 53.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.